NSEDisclosure under SEBI Takeover Regulations6 Jul 2026 · 6 Jul 2026, 11:58 am
Disclosure under SEBI Takeover Regulations
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI SummaryRegulatory
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.